Management of Infantile Hemangiomas.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 133, doi. 10.1007/s40272-013-0008-6
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2013 AND VI 15 AND IP 2
Results: 7
1
2
Cancer Pharmacogenomics in Children: Research Initiatives and Progress to Date.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 71, doi. 10.1007/s40272-013-0021-9
- By:
- Publication type:
- Article
3
Bipolar Depression in Pediatric Populations.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 83, doi. 10.1007/s40272-013-0022-8
- By:
- Publication type:
- Article
4
Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 139, doi. 10.1007/s40272-013-0016-6
- By:
- Publication type:
- Article
5
The Cost Effectiveness of Licensed Oromucosal Midazolam (Buccolam) for the Treatment of Children Experiencing Acute Epileptic Seizures: An Approach When Trial Evidence is Limited.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 151, doi. 10.1007/s40272-013-0009-5
- By:
- Publication type:
- Article
6
Pharmacokinetics of Antibacterial Agents in the CSF of Children and Adolescents.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 93, doi. 10.1007/s40272-013-0017-5
- By:
- Publication type:
- Article
7
Proton Pump Inhibitors in Pediatrics.
- Published in:
- Pediatric Drugs, 2013, v. 15, n. 2, p. 119, doi. 10.1007/s40272-013-0012-x
- By:
- Publication type:
- Article